MLchartDataset catalogue

pneumococcal polyvalent vaccine

Term · Oncology and biomedicine · MLC-T-ONC-016127

An polyvalent vaccine used to prevent infection by the bacterium Streptococcus pneumoniae. Pneumococcal polyvalent vaccine contains higly purified capsular antigens from the 23 most prevalent or invasive pneumococcal types of Streptococcus pneumoniae to ensure cross-protection. Following vaccination, protective capsular type-specific antibody levels typically develop by the third week; serotype-specific antibody levels generally decline after 5-10 years.

Table 1. Record
IdentifierMLC-T-ONC-016127
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016127",
  "term": "pneumococcal polyvalent vaccine",
  "field": "Oncology and biomedicine",
  "definition": "An polyvalent vaccine used to prevent infection by the bacterium Streptococcus pneumoniae. Pneumococcal polyvalent vaccine contains higly purified capsular antigens from the 23 most prevalent or invasive pneumococcal types of Streptococcus pneumoniae to ensure cross-protection. Following vaccination, protective capsular type-specific antibody levels typically develop by the third week; serotype-specific antibody levels generally decline after 5-10 years.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/pneumococcal-polyvalent-vaccine/"
}

Record 13,387 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.